Xtant Medical (NYSEAMERICAN:XTNT) will be releasing its earnings data before the market opens on Wednesday, May 15th.
Xtant Medical (NYSEAMERICAN:XTNT) last issued its quarterly earnings data on Monday, April 1st. The medical device company reported ($0.32) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.16) by ($0.16). The company had revenue of $18.26 million during the quarter.
XTNT remained flat at $$3.01 during trading on Thursday. The company had a trading volume of 192 shares, compared to its average volume of 10,889. Xtant Medical has a 1-year low of $1.61 and a 1-year high of $7.70.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by American Banking News and is the property of of American Banking News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2019/05/09/xtant-medical-xtnt-to-release-earnings-on-wednesday.html.
About Xtant Medical
Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.
Further Reading: What is the Bid-Ask Spread?
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.